ATP2A2 and type 2 diabetes mellitus: Our findings thus provide comprehensive evidence to indicate that by increasing the expression of SERCA2, ISTA treatment can promote a significant improvement in bone mechano-responsiveness of T2D mice via the osteocyte-mediated regulation of osteoblasts and osteoclasts.